Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework
- PMID: 35956081
- PMCID: PMC9369763
- DOI: 10.3390/jcm11154464
Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework
Abstract
Addressing factors modulating COVID-19 is crucial since abundant clinical evidence shows that outcomes are markedly heterogeneous between patients. This requires identifying the factors and understanding how they mechanistically influence COVID-19. Here, we describe how eleven selected factors (age, sex, genetic factors, lipid disorders, heart failure, gut dysbiosis, diet, vitamin D deficiency, air pollution and exposure to chemicals) influence COVID-19 by applying the Adverse Outcome Pathway (AOP), which is well-established in regulatory toxicology. This framework aims to model the sequence of events leading to an adverse health outcome. Several linear AOPs depicting pathways from the binding of the virus to ACE2 up to clinical outcomes observed in COVID-19 have been developed and integrated into a network offering a unique overview of the mechanisms underlying the disease. As SARS-CoV-2 infectibility and ACE2 activity are the major starting points and inflammatory response is central in the development of COVID-19, we evaluated how those eleven intrinsic and extrinsic factors modulate those processes impacting clinical outcomes. Applying this AOP-aligned approach enables the identification of current knowledge gaps orientating for further research and allows to propose biomarkers to identify of high-risk patients. This approach also facilitates expertise synergy from different disciplines to address public health issues.
Keywords: COVID-19; SARS-CoV-2 infection; adverse outcome pathway; age; co-morbidities; environment; lifestyle; modulating factors; pre-existing conditions; sex.
Conflict of interest statement
The authors declare no conflict of interest. This study is solely associated with individual scientist participation and their expressions of interest and opinions; it does not represent the official position of any institution.
Figures





Similar articles
-
Mechanisms Leading to Gut Dysbiosis in COVID-19: Current Evidence and Uncertainties Based on Adverse Outcome Pathways.J Clin Med. 2022 Sep 14;11(18):5400. doi: 10.3390/jcm11185400. J Clin Med. 2022. PMID: 36143044 Free PMC article. Review.
-
The Adverse Outcome Pathway Framework Applied to Neurological Symptoms of COVID-19.Cells. 2022 Oct 28;11(21):3411. doi: 10.3390/cells11213411. Cells. 2022. PMID: 36359807 Free PMC article. Review.
-
COVID-19 through Adverse Outcome Pathways: Building networks to better understand the disease - 3rd CIAO AOP Design Workshop.ALTEX. 2022;39(2):322–335. doi: 10.14573/altex.2112161. Epub 2022 Jan 3. ALTEX. 2022. PMID: 35032963 Free PMC article.
-
Building an Adverse Outcome Pathway network for COVID-19.Front Syst Biol. 2024 Jun 6;4:1384481. doi: 10.3389/fsysb.2024.1384481. Front Syst Biol. 2024. PMID: 40206642 Free PMC article.
-
Development of a putative adverse outcome pathway network for male rat reproductive tract abnormalities with specific considerations for the androgen sensitive window of development.Curr Res Toxicol. 2021 Jul 22;2:254-271. doi: 10.1016/j.crtox.2021.07.002. eCollection 2021. Curr Res Toxicol. 2021. PMID: 34401750 Free PMC article.
Cited by
-
Mechanisms Leading to Gut Dysbiosis in COVID-19: Current Evidence and Uncertainties Based on Adverse Outcome Pathways.J Clin Med. 2022 Sep 14;11(18):5400. doi: 10.3390/jcm11185400. J Clin Med. 2022. PMID: 36143044 Free PMC article. Review.
-
Gut as an Alternative Entry Route for SARS-CoV-2: Current Evidence and Uncertainties of Productive Enteric Infection in COVID-19.J Clin Med. 2022 Sep 26;11(19):5691. doi: 10.3390/jcm11195691. J Clin Med. 2022. PMID: 36233559 Free PMC article. Review.
-
A Pragmatic Framework for the Application of New Approach Methodologies in One Health Toxicological Risk Assessment.Toxicol Sci. 2023 Feb 14;192(2):155-77. doi: 10.1093/toxsci/kfad012. Online ahead of print. Toxicol Sci. 2023. PMID: 36782355 Free PMC article.
-
CIAO: a living experiment in interdisciplinary large-scale collaboration facilitated by the Adverse Outcome Pathway framework.Front Public Health. 2023 Aug 10;11:1212544. doi: 10.3389/fpubh.2023.1212544. eCollection 2023. Front Public Health. 2023. PMID: 37637826 Free PMC article.
-
The Adverse Outcome Pathway Framework Applied to Neurological Symptoms of COVID-19.Cells. 2022 Oct 28;11(21):3411. doi: 10.3390/cells11213411. Cells. 2022. PMID: 36359807 Free PMC article. Review.
References
-
- Nymark P., Sachana M., Leite S.B., Sund J., Krebs C.E., Sullivan K., Edwards S., Viviani L., Willett C., Landesmann B., et al. Systematic Organization of COVID-19 Data Supported by the Adverse Outcome Pathway Framework. Front. Public Health. 2021;9:638605. doi: 10.3389/fpubh.2021.638605. - DOI - PMC - PubMed
-
- Ankley G.T., Bennett R.S., Erickson R.J., Hoff D.J., Hornung M.W., Johnson R.D., Mount D.R., Nichols J.W., Russom C.L., Schmieder P.K., et al. Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment. Environ. Toxicol. Chem. 2010;29:730–741. doi: 10.1002/etc.34. - DOI - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous